Humoral and cell-mediated response elicited by SARS-CoV-2 mRNA vaccine BNT162b2 e in healthcare workers: a longitudinal observational study
Sabato 25 settembre 2021
circa 1 minuti di lettura
Journal and Affiliations:
Clinical Microbiology Infection, 25 settembre 2021
Luca Simonelli, Istituto di Ricerca in Biomedicina, Bellinzona
Luca Varani, Istituto di Ricerca in Biomedicina, Bellinzona
Tags:
antibody response
mRNA vaccine
SARS-CoV-2
T-cell response
viral variants
Authors:
Luca Simonelli
Luca Varani